The stock of American Vanguard Corp. (NYSE:AVD) hit a new 52-week high and has $18.56 target or 4.00% above today’s $17.85 share price. The 5 months bullish chart indicates low risk for the $537.75 million company. The 1-year high was reported on Nov, 22 by Barchart.com. If the $18.56 price target is reached, the company will be worth $21.51 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 30,500 shares traded hands. American Vanguard Corp. (NYSE:AVD) has risen 9.61% since April 20, 2016 and is uptrending. It has outperformed by 5.05% the S&P500.
American Vanguard Corp. (NYSE:AVD) Ratings Coverage
Out of 3 analysts covering American Vanguard Corp. (NYSE:AVD), 0 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 0 are positive. $19 is the highest target while $10 is the lowest. The $12.25 average target is -31.37% below today’s ($17.85) stock price. American Vanguard Corp. has been the topic of 6 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Zacks downgraded the shares of AVD in a report on Wednesday, August 5 to “Hold” rating. The rating was downgraded by Piper Jaffray to “Underweight” on Monday, January 4. Roth Capital initiated American Vanguard Corp. (NYSE:AVD) on Friday, March 11 with “Buy” rating. The firm has “Neutral” rating by Roth Capital given on Wednesday, May 4. The company was downgraded on Wednesday, July 13 by BB&T Capital. The company was maintained on Tuesday, November 3 by Piper Jaffray.
According to Zacks Investment Research, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms.”
Insitutional Activity: The institutional sentiment increased to 1.4 in 2016 Q2. Its up 0.70, from 0.7 in 2016Q1. The ratio improved, as 19 funds sold all American Vanguard Corp. shares owned while 44 reduced positions. 12 funds bought stakes while 32 increased positions. They now own 21.56 million shares or 3.36% less from 22.31 million shares in 2016Q1.
Royal Comml Bank Of Canada owns 42,320 shares or 0% of their US portfolio. Menta Capital Lc holds 0.09% or 41,053 shares in its portfolio. Bnp Paribas Arbitrage Sa, a New York-based fund reported 8,018 shares. Legal & General Gru Public Limited Co accumulated 0% or 5,547 shares. Globeflex Capital L P accumulated 0.3% or 71,706 shares. Indexiq Advsrs Ltd Liability Corp accumulated 0.01% or 7,996 shares. Pinebridge Invests Limited Partnership owns 3,016 shares or 0% of their US portfolio. Ny State Common Retirement Fund has 29,100 shares for 0% of their US portfolio. Walthausen And Co Ltd Liability Co has 687,018 shares for 1.08% of their US portfolio. Sheets Smith Wealth Management, a North Carolina-based fund reported 11,220 shares. Tiaa Cref Inv Management Limited Com has invested 0% of its portfolio in American Vanguard Corp. (NYSE:AVD). Gotham Asset Management Ltd Liability Company reported 12,564 shares or 0% of all its holdings. The Ohio-based Strs Ohio has invested 0% in American Vanguard Corp. (NYSE:AVD). Hartford Inv Management has invested 0% of its portfolio in American Vanguard Corp. (NYSE:AVD). The Pennsylvania-based Cim Invest Mangement has invested 0.21% in American Vanguard Corp. (NYSE:AVD).
Insider Transactions: Since August 16, 2016, the stock had 1 buy, and 2 insider sales for $76,150 net activity. Another trade for 5,000 shares valued at $86,700 was sold by Rizzi John. Trogele Ulrich bought $79,550 worth of stock. Hendrix Scott had sold 4,000 shares worth $69,000.
Another recent and important American Vanguard Corp. (NYSE:AVD) news was published by Thestreet.com which published an article titled: “Commit To Purchase American Vanguard Corp. At $12.50, Earn 11.2% Annualized …” on November 04, 2016.
AVD Company Profile
American Vanguard Corporation (AVD), incorporated on January 2, 1969, operates as a holding company. The Firm conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance). The Company, through AMVAC, develops and markets products for agricultural, commercial and consumer uses. The Firm makes and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals, which include insecticides, fungicides, herbicides, molluscicides, growth regulators and soil fumigants, are marketed in liquid, powder and granular forms.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.